Vanderbilt Kennedy Center Archive
-
June 21, 2023
Elise McMillan to retire as Vanderbilt Kennedy Center UCEDD director
Elise McMillan, JD, has announced she will retire from the Vanderbilt Kennedy Center this month. -
January 26, 2023
Hine to lead DDM, TRIAD outreach and training efforts
Jeffrey Hine, PhD, has been named director of Primary Care Outreach and Training for the Vanderbilt Kennedy Center (VKC), the VKC Treatment and Research Institute for Autism Spectrum Disorders and the Division of Developmental Medicine. -
January 17, 2023
Vanderbilt Kennedy Center seeks adults 18-30 to study effects of noise on brain activity
The Vanderbilt Kennedy Center is seeking adult participants (ages 18 to 30) for a research study investigating the effects of different noise conditions on brain activity during the Attentional Network Task. -
November 10, 2022
Kennedy Center seeks participants for disabilities research learning sessions
In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD. -
September 8, 2022
Juárez named director of behavior analysis
Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center. -
April 28, 2022
Rajaraman named TRIAD director of behavioral analysis
Adithyan Rajaraman, PhD, BCBA-D, LBA, has been named director of the Vanderbilt Kennedy Center Treatment & Research Institute for Autism Spectrum Disorders. -
December 6, 2021
Potential Rett syndrome drug shows promising results in phase 3 trial
A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.